Skip to Content
U.S. National Institutes of Health
Last Updated: 08/31/15


While the mortality rate has declined among most population groups over the past twenty years, cancers of the lung and bronchus are still the leading cause of cancer death among both males and females in the United States. According to estimates of the American Cancer Society, approximately 221,200 new cases of lung and bronchus cancer and 158,040 deaths were expected to be reported in the year 2015. The high mortality rate is due largely to the fact that a majority of these cancers are not detected until the disease has reached an advanced stage, when treatment is less effective. Because of the huge burden of lung cancer in terms of morbidity and mortality, lung cancer was an early focus of the SPORE Program. Three Lung SPOREs were funded in 1992 and additional SPOREs were added raising the number to seven in 2003. Currently there are 4 fully funded SPOREs in lung cancer.

Johns Hopkins University

Stephen B. Baylin, MD [Click Here]
Professor of Oncology & Medicine
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Bunting Blaustein Cancer Research Building
1650 Orleans Street, Room 541
Baltimore, Maryland 21231
Tel: (410) 955-8506
Fax: (410) 614-9884

University of Colorado Cancer Center

Paul A. Bunn, Jr., MD [Click Here]
University of Colorado Health Science Center
Department of Medicine
4200 East Ninth Avenue
Box B - 188
Denver, Colorado 80262
Tel: (303) 315-3007
Fax: (303) 315-3304

For more information on this specific SPORE’s institution, please visit:

University of Pittsburgh

Mark A. Socinski, MD [Click Here]
Professor of Medicine and Cardiothoraci Surgery
Director, Lung Cancer Section, Division of Hematology/Oncolory
University of Pittsburgh
5150 Centre Avenue
Fifth Floor, Room 556
Pittsburgh, PA 15232
Phone: (412) 648-6578
Fax: (412) 648-6579

For more information on this specific SPORE’s institution, please visit:

University of Texas/Southwestern Medical Center

John D. Minna, MD [Click Here]
Professor, Internal Medicine and Pharmacology
Director, Harmon Center for Therapeutic Oncology Research
Department of Internal Medicine
University of Texas Southwestern Medical Center
Harmon Center for Therapeutic Oncology
5323 Harry Hines Boulevard
Room NB8-206
Dallas, Texas 75390
Tel: (214) 648-4900
Fax: (214) 648-4940

For more information on this specific SPORE’s institution, please visit:

Yale University

Roy S. Herbst, MD, PhD [Click Here]
Ensign Professor of Medicine
Professor of Pharmacology
Chief of Medical Oncology
Director, Thoracic Oncology Research Program
Associate Director for Translational Research
Yale Comprehensive Cancer Center
Yale School of Medicine
333 Cedar Street, WWW221
New Haven, CT  06520-8028
Phone: 203-785-6879
Fax: 203-737-5698